These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25204278)

  • 1. Basal ganglia echogenicity in tauopathies.
    Sadowski K; Serafin-Król M; Szlachta K; Friedman A
    J Neural Transm (Vienna); 2015 Jun; 122(6):863-5. PubMed ID: 25204278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.
    Walter U; Dressler D; Wolters A; Probst T; Grossmann A; Benecke R
    Neurology; 2004 Aug; 63(3):504-9. PubMed ID: 15304582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
    Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
    Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
    Walter U; Niehaus L; Probst T; Benecke R; Meyer BU; Dressler D
    Neurology; 2003 Jan; 60(1):74-7. PubMed ID: 12525721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: a systematic review and meta-analysis.
    Wen Y; Zhou H; Xia M; Liu Q; Quan H; Fang L
    Neurol Sci; 2024 Feb; 45(2):455-465. PubMed ID: 37819487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sonography of the parenchyma in Parkinson's disease].
    Hagenah J; Seidel G
    Nervenarzt; 2010 Oct; 81(10):1189-95. PubMed ID: 20802993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.
    Richter D; Katsanos AH; Schroeder C; Tsivgoulis G; Paraskevas GP; Müller T; Alexandrov AV; Gold R; Tönges L; Krogias C
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra echogenicity in progressive supranuclear palsy.
    Ebentheuer J; Canelo M; Trautmann E; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):773-7. PubMed ID: 20198715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial brain sonography findings in two main variants of progressive supranuclear palsy.
    Kostić VS; Mijajlović M; Smajlović D; Lukić MJ; Tomić A; Svetel M
    Eur J Neurol; 2013 Mar; 20(3):552-557. PubMed ID: 23173978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.
    Smajlovic D; Ibrahimagic OC
    Med Arch; 2017 Aug; 71(4):261-264. PubMed ID: 28974846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial brain parenchyma sonography in movement disorders: state of the art.
    Walter U; Behnke S; Eyding J; Niehaus L; Postert T; Seidel G; Berg D
    Ultrasound Med Biol; 2007 Jan; 33(1):15-25. PubMed ID: 17189043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
    Walter U; Wittstock M; Benecke R; Dressler D
    J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
    Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
    Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
    Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
    Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial brain sonography for Parkinsonian syndromes.
    Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
    J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.